1. Home
  2. TKLF vs RGNT Comparison

TKLF vs RGNT Comparison

Compare TKLF & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yoshitsu Co. Ltd

TKLF

Yoshitsu Co. Ltd

N/A

Current Price

$1.98

Market Cap

8.2M

ML Signal

N/A

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$1.85

Market Cap

6.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TKLF
RGNT
Founded
2006
2004
Country
Japan
Israel
Employees
N/A
8
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
6.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
TKLF
RGNT
Price
$1.98
$1.85
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
106.3K
3.9M
Earning Date
12-19-2025
05-05-2026
Dividend Yield
10.97%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$1.23
52 Week High
$4.32
$8.35

Technical Indicators

Market Signals
Indicator
TKLF
RGNT
Relative Strength Index (RSI) 40.41 47.46
Support Level N/A $1.82
Resistance Level $2.41 $3.35
Average True Range (ATR) 0.24 0.55
MACD 0.00 0.04
Stochastic Oscillator 14.92 13.32

Price Performance

Historical Comparison
TKLF
RGNT

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: